Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA
As published in the Federal Register of 13 October 2010 (75 FR 62820). Both dates from the notice: the Federal Register issue of 13 October 2010 and the notice's DATES caption, which states the same day as the effective date.
- Issued by
- United States Department of Health and Human Services
- Authors credited
- No authorship claim recorded yet. The source record lists Federal Register (Office of the Federal Register, National Archives) via govinfo.gov.
- Dates
- Published 2010-10-13 issue evidence
- Effective 2010-10-13
Both dates from the notice: the Federal Register issue of 13 October 2010 and the notice's DATES caption, which states the same day as the effective date.
- Exact source
- Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA (75 FR 62820) Federal Register (Office of the Federal Register, National Archives) via govinfo.gov · publication date unknown · Retrieved for the candidate pack on 2026-10-28 (SHA-256 d3bfd95a1e3ae4d212505081166f0f8bb7475845e225ae643e6d4a03a93b7e56). Federal Register print of 13 October 2010, Vol. 75, No. 197, pp. 62820-62832, FR Doc. 2010-25728. The notice publishes the final Guidance in full, after the comment responses. Retrieved again at admission on 2026-10-30 (SHA-256 d3bfd95a1e3ae4d212505081166f0f8bb7475845e225ae643e6d4a03a93b7e56, the same bytes).
Appears in
No collection holds a record about this document yet.
Versions
us-hhs-synthetic-nucleic-acid-screening-guidance: 3 recorded versions, oldest first, published by United States Department of Health and Human Services. A version is shown as replacing another only where a record says so. Date order alone never implies it.
- 2010-10-13 · effectiveAs published in the Federal Register of 13 October 2010 (75 FR 62820) (this version)
- 2022-04-29 · publishedAs published in the Federal Register of 29 April 2022 (87 FR 25495)
- 2023-10-13 · publishedAs published in the Federal Register of 13 October 2023 (88 FR 70998)
This version
- Replaced byThe 2023 Screening Framework Guidance for Providers and Users of Synthetic Nucleic Acids states that advances in the field motivated the United States Government to review and revise the 2010 Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA, and cites the 2010 guidance at 75 FR 62820.2023-10-13 · publication · Stated in source · Supported Inspect claim & evidence ↗Screening Framework Guidance for Providers and Users of Synthetic Nucleic Acids: document page →
Provisions in this version · 3 quoted
A limited selection of quoted provisions: what this edition says about thresholds, required actions, who decides and exceptions, and other statements of the text. It is not a full summary and says nothing about implementation. A “not found” record states which part of the edition was inspected. It is not a claim that the text was deleted.
- Threshold or triggerAddressees: the final Guidance is directed to all providers of synthetic double-stranded DNA“the final Guidance is directed to all providers of synthetic dsDNA”Response to comments on scope, 75 FR 62823Inspect claim & evidence ↗
- Stated dateEffective date of the 2010 Guidance (DATES caption)“The Guidance is effective on October 13, 2010.”DATES, 75 FR 62820Inspect claim & evidence ↗
- StandingFollowing the Guidance is voluntary“Following this Guidance is voluntary, though many specific recommendations serve to remind providers of their obligations under existing regulations.”SUMMARY, 75 FR 62820Inspect claim & evidence ↗
Issue and authorship records
Documentary relations
Each relation is listed separately. Citing, crediting and reporting the use of a method are different acts, and none of them shows agreement or influence by itself.
Not recorded for this document: cites · cited by · explicitly credits · reports using a method from · method reported as used by · applies parts of · parts applied by · discusses · reports evaluation of. A missing record does not show that the relation does not exist.